Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons.

Alivernini S, Galeazzi M, Peleg H, Tolusso B, Gremese E, Ferraccioli G, Naparstek Y.

Autoimmun Rev. 2017 Nov;16(11):1096-1102. doi: 10.1016/j.autrev.2017.09.002. Epub 2017 Sep 9. Review.

PMID:
28899798
2.

Protective antibodies against HSP60 for autoimmune inflammatory diseases.

Ulmansky R, Naparstek Y.

Clin Immunol. 2018 Jan;186:63. doi: 10.1016/j.clim.2017.07.016. Epub 2017 Jul 24. No abstract available.

PMID:
28751270
3.

A liposomal steroid nano-drug for treating systemic lupus erythematosus.

Moallem E, Koren E, Ulmansky R, Pizov G, Barlev M, Barenholz Y, Naparstek Y.

Lupus. 2016 Oct;25(11):1209-16. doi: 10.1177/0961203316636468. Epub 2016 Mar 7.

PMID:
26957351
4.

HSP60: a double edge sword in autoimmunity.

Landstein D, Ulmansky R, Naparstek Y.

Oncotarget. 2015 Oct 20;6(32):32299-300. doi: 10.18632/oncotarget.5869. No abstract available.

5.

Is B Cell-Targeted Therapy Effective in Systemic Lupus Erythematosus?

Paran D, Naparstek Y.

Isr Med Assoc J. 2015 Feb;17(2):98-103. Review.

6.

Global implementation of genomic medicine: We are not alone.

Manolio TA, Abramowicz M, Al-Mulla F, Anderson W, Balling R, Berger AC, Bleyl S, Chakravarti A, Chantratita W, Chisholm RL, Dissanayake VH, Dunn M, Dzau VJ, Han BG, Hubbard T, Kolbe A, Korf B, Kubo M, Lasko P, Leego E, Mahasirimongkol S, Majumdar PP, Matthijs G, McLeod HL, Metspalu A, Meulien P, Miyano S, Naparstek Y, O'Rourke PP, Patrinos GP, Rehm HL, Relling MV, Rennert G, Rodriguez LL, Roden DM, Shuldiner AR, Sinha S, Tan P, Ulfendahl M, Ward R, Williams MS, Wong JE, Green ED, Ginsburg GS.

Sci Transl Med. 2015 Jun 3;7(290):290ps13. doi: 10.1126/scitranslmed.aab0194. Review.

7.

A Humanized Monoclonal Antibody against Heat Shock Protein 60 Suppresses Murine Arthritis and Colitis and Skews the Cytokine Balance toward an Anti-Inflammatory Response.

Ulmansky R, Landstein D, Moallem E, Loeb V, Levin A, Meyuhas R, Katzavian G, Yair S, Naparstek Y.

J Immunol. 2015 Jun 1;194(11):5103-9. doi: 10.4049/jimmunol.1500023. Epub 2015 Apr 22.

8.

The effect of medical students' gender, ethnicity and attitude towards poetry-reading on the evaluation of a required, clinically-integrated poetry-based educational intervention.

Muszkat M, Barak O, Lalazar G, Mazal B, Schneider R, Levi IM, Cohen MJ, Canetti L, Ben Yehuda A, Naparstek Y.

BMC Med Educ. 2014 Sep 15;14:188. doi: 10.1186/1472-6920-14-188.

9.

In-/off-label use of biologic therapy in systemic lupus erythematosus.

Gatto M, Kiss E, Naparstek Y, Doria A.

BMC Med. 2014 Feb 17;12:30. doi: 10.1186/1741-7015-12-30. Review.

10.

Extracorporeal immunoadsorption of antibodies against the VRT-101 laminin epitope in systemic lupus erythematosus: a feasibility evaluation study.

Hershko AY, Scheiman-Elazari A, Aamar S, Naparstek Y.

Immunol Res. 2013 Jul;56(2-3):376-81. doi: 10.1007/s12026-013-8412-0.

PMID:
23584986
11.

Pulmonary hemorrhage in antiphospholipid antibody syndrome.

Scheiman Elazary A, Cohen MJ, Aamar S, Dranitzki Z, Tayer-Shifman O, Mevorach D, Ben-Chetrit E, Naparstek Y.

J Rheumatol. 2012 Aug;39(8):1628-31. doi: 10.3899/jrheum.120205. Epub 2012 Jul 1.

PMID:
22753647
12.

Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines.

Ulmansky R, Turjeman K, Baru M, Katzavian G, Harel M, Sigal A, Naparstek Y, Barenholz Y.

J Control Release. 2012 Jun 10;160(2):299-305. doi: 10.1016/j.jconrel.2011.12.024. Epub 2011 Dec 28.

PMID:
22226777
13.

Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome.

Scheiman Elazary A, Klahr PP, Hershko AY, Dranitzki Z, Rubinow A, Naparstek Y.

Lupus. 2012 Apr;21(4):438-40. doi: 10.1177/0961203311422713. Epub 2011 Oct 12.

PMID:
21993385
14.

Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46.

Gur C, Enk J, Kassem SA, Suissa Y, Magenheim J, Stolovich-Rain M, Nir T, Achdout H, Glaser B, Shapiro J, Naparstek Y, Porgador A, Dor Y, Mandelboim O.

J Immunol. 2011 Sep 15;187(6):3096-103. doi: 10.4049/jimmunol.1101269. Epub 2011 Aug 17.

15.

Teaching empathy through poetry: a clinically based model.

Muszkat M, Yehuda AB, Moses S, Naparstek Y.

Med Educ. 2010 May;44(5):503. doi: 10.1111/j.1365-2923.2010.03673.x. Epub 2010 Mar 30. No abstract available.

PMID:
20374467
16.

An antibody profile of systemic lupus erythematosus detected by antigen microarray.

Fattal I, Shental N, Mevorach D, Anaya JM, Livneh A, Langevitz P, Zandman-Goddard G, Pauzner R, Lerner M, Blank M, Hincapie ME, Gafter U, Naparstek Y, Shoenfeld Y, Domany E, Cohen IR.

Immunology. 2010 Jul;130(3):337-43. doi: 10.1111/j.1365-2567.2010.03245.x. Epub 2010 Feb 26.

17.

The activating receptor NKp46 is essential for the development of type 1 diabetes.

Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N, Achdout H, Ghadially H, Dor Y, Nir T, Doviner V, Hershkovitz O, Mendelson M, Naparstek Y, Mandelboim O.

Nat Immunol. 2010 Feb;11(2):121-8. doi: 10.1038/ni.1834. Epub 2009 Dec 20.

PMID:
20023661
18.

Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus.

Berkun Y, Verbovetski I, Ben-Ami A, Paran D, Caspi D, Krispin A, Trahtemberg U, Gill O, Naparstek Y, Mevorach D.

Eur J Immunol. 2008 Oct;38(10):2896-904. doi: 10.1002/eji.200838342.

19.

[Reorganization of the Department of Medicine--how we should respond to the changes in internal medicine].

Ilan Y, Naparstek Y.

Harefuah. 2008 Mar;147(3):186-191, 280. Hebrew.

PMID:
18488855
20.

Increased intracranial pressure related to systemic lupus erythematosus: a 26-year experience.

Hershko AY, Berkun Y, Mevorach D, Rubinow A, Naparstek Y.

Semin Arthritis Rheum. 2008 Oct;38(2):110-5. doi: 10.1016/j.semarthrit.2007.09.007. Epub 2008 Jan 25.

PMID:
18221986
21.

Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis.

Avnir Y, Ulmansky R, Wasserman V, Even-Chen S, Broyer M, Barenholz Y, Naparstek Y.

Arthritis Rheum. 2008 Jan;58(1):119-29. doi: 10.1002/art.23230.

22.

Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption.

Amital H, Heilweil-Harel M, Ulmansky R, Harlev M, Toubi E, Hershko A, Naparstek Y.

Rheumatology (Oxford). 2007 Sep;46(9):1433-7. Epub 2007 Aug 7.

PMID:
17686790
23.

Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus.

Uziel Y, Gorodnitski N, Mukamel M, Padeh S, Brik R, Barash J, Mevorach D, Berkun Y, Tauber T, Press J, Harel L, Navon P, Rubenstein M, Naparstek Y, Hashkes PJ; Pediatric Rheumatology Study Group Of Israel @ SLERI.

Lupus. 2007;16(2):142-6.

PMID:
17402372
24.

Ariel Sharon's illness: should we dedicate a medical journal issue to a single case study?

Naparstek Y.

Isr Med Assoc J. 2006 Nov;8(11):739-40. No abstract available.

25.

Wegener granulomatosis with back pain, periaortitis, and dural inflammation developing while receiving monthly cyclophosphamide.

Levin A, Kasem S, Mader R, Naparstek Y, Friedman G, Ben-Yehuda A.

J Clin Rheumatol. 2006 Dec;12(6):294-7.

PMID:
17149061
26.

Autoimmunity in the era of genomics and proteomics.

Hershko AY, Naparstek Y.

Autoimmun Rev. 2006 Apr;5(4):230-3. Epub 2005 Aug 8. Review.

PMID:
16697962
27.

Treatment with a laminin-derived peptide suppresses lupus nephritis.

Amital H, Heilweil M, Ulmansky R, Szafer F, Bar-Tana R, Morel L, Foster MH, Mostoslavsky G, Eilat D, Pizov G, Naparstek Y.

J Immunol. 2005 Oct 15;175(8):5516-23.

28.

Alveolar hemorrhage in cryoglobulinemia--an indicator of poor prognosis.

Amital H, Rubinow A, Naparstek Y.

Clin Exp Rheumatol. 2005 Sep-Oct;23(5):616-20.

PMID:
16173236
29.

Removal of pathogenic autoantibodies by immunoadsorption.

Hershko AY, Naparstek Y.

Ann N Y Acad Sci. 2005 Jun;1051:635-46. Review.

PMID:
16127004
30.

The future of the treatment of systemic lupus erythematosus.

Schattner A, Naparstek Y.

Clin Exp Rheumatol. 2005 Mar-Apr;23(2):254-60. Review.

PMID:
15895901
31.

Hyperacute renal failure as the initial presentation of systemic lupus erythematosus.

Arbel O, Pizov G, Ben-Yehuda A, Rubinow A, Naparstek Y, Amital H.

Lupus. 2005;14(4):331-3.

PMID:
15864922
32.

Immune modulation for prevention of type 1 diabetes mellitus.

Raz I, Eldor R, Naparstek Y.

Trends Biotechnol. 2005 Mar;23(3):128-34. Review.

PMID:
15734555
33.

Susceptibility and resistance to experimental adjuvant arthritis.

Hershko AY, Ulmansky R, Moallem E, Naparstek Y.

Front Biosci. 2004 Sep 1;9:3268-75.

PMID:
15353356
34.

The coexistence of Sweet's syndrome and Still's disease--is it merely a coincidence?

Elinav H, Maly A, Ilan Y, Rubinow A, Naparstek Y, Amital H.

J Am Acad Dermatol. 2004 May;50(5 Suppl):S90-2.

PMID:
15097938
35.

Small fiber neuropathy due to isolated vasculitis of the peripheral nervous system.

Zafrir B, Zimmerman M, Fellig Y, Naparstek Y, Reichman N, Flatau E.

Isr Med Assoc J. 2004 Mar;6(3):183-4. No abstract available.

36.

Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery.

Berkun Y, Elami A, Meir K, Mevorach D, Naparstek Y.

J Thorac Cardiovasc Surg. 2004 Feb;127(2):414-20.

37.

Reorganization of a department of medicine in Israel: the Hadassah experience.

Naparstek Y, Cohen R.

Isr Med Assoc J. 2003 Apr;5(4):281-5. No abstract available.

38.

[Retroperitoneal fibrosis--clinical response to steroid treatment].

Elinav H, Hershko A, Leibovitch G, Naparstek Y.

Harefuah. 2003 Mar;142(3):166-9, 240. Hebrew.

PMID:
12696465
39.

Structural considerations of autoantibodies.

Madaio MP, Naparstek Y.

Lupus. 2002;11(12):774-5. Review.

PMID:
12529037
40.

Henoch Schonlein purpura in children and adults: is it one entity?

Ilan Y, Naparstek Y.

Semin Arthritis Rheum. 2002 Dec;32(3):139-40. Review. No abstract available.

PMID:
12528077
41.

A man with swollen calf and discoloration of the foot.

Berkun Y, Sade K, Naparstek Y.

Postgrad Med J. 2002 May;78(919):300, 304. No abstract available.

42.

Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion.

Ulmansky R, Cohen CJ, Szafer F, Moallem E, Fridlender ZG, Kashi Y, Naparstek Y.

J Immunol. 2002 Jun 15;168(12):6463-9.

43.

Koch's postulates and autoimmunity: an opposing viewpoint.

Putterman C, Naparstek Y.

Arch Immunol Ther Exp (Warsz). 1999;47(1):25-32. Review.

PMID:
11729825
44.

The enigma of antigen selection and antigen recognition in systemic lupus erythematosus.

Mevorach D, Naparstek Y.

Isr Med Assoc J. 2001 Nov;3(11):841-2. No abstract available.

45.

Constitutive hyperhistaminaemia: a possible mechanism for recurrent anaphylaxis.

Hershko AY, Dranitzki Z, Ulmanski R, Levi-Schaffer F, Naparstek Y.

Scand J Clin Lab Invest. 2001;61(6):449-52.

PMID:
11681534
46.

Anti-DNA antibodies cross-reacting with laminin inhibit trophoblast attachment and migration: implications for recurrent pregnancy loss in SLE patients.

Qureshi F, Yang Y, Jaques SM, Johnson MP, Naparstek Y, Ulmansky R, Schuger L.

Am J Reprod Immunol. 2000 Sep;44(3):136-42.

PMID:
11028899
47.

Gastric-Mucocutaneous gammadelta T cell lymphoma: possible association with Epstein-Barr virus?

Shapira MY, Caspi O, Amir G, Zlotogorski A, Naparstek Y.

Leuk Lymphoma. 1999 Oct;35(3-4):397-401.

PMID:
10706465
48.

Abundance of house dust mites in relation to climate in contrasting agricultural settlements in Israel.

Mumcuoglu KY, Gat Z, Horowitz T, Miller J, Bar-Tana R, Ben-Zvi A, Naparstek Y.

Med Vet Entomol. 1999 Jul;13(3):252-8.

PMID:
10514050
49.

Anti-DNA autoantibodies: a puzzle of autoimmune phenomena.

Eilat D, Naparstek Y.

Immunol Today. 1999 Aug;20(8):339-42. No abstract available.

PMID:
10475679
50.

Plasma immunoglobulins in patients with severe ovarian hyperstimulation syndrome.

Abramov Y, Naparstek Y, Elchalal U, Lewin A, Schechter E, Schenker JG.

Fertil Steril. 1999 Jan;71(1):102-5.

PMID:
9935124

Supplemental Content

Loading ...
Support Center